Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2022
Dec. 31, 2021
CURRENT ASSETS    
Cash $ 899,290 $ 1,499,866
Prepaid expenses and other current assets 66,159 135,014
Deferred offering costs 35,000
TOTAL CURRENT ASSETS 965,449 1,669,880
TOTAL ASSETS 965,449 1,669,880
CURRENT LIABILITIES    
Accounts payable and accrued expenses 1,020,650 569,321
Accrued payroll and related expenses 810,454 95,400
Accrued Series B preferred stock dividends 266,619 153,343
Convertible notes payable, net of discount 559,625 532,400
Notes payable - related parties 7,500 7,500
Debentures 35,000
TOTAL CURRENT LIABILITIES 2,664,848 1,392,964
TOTAL LIABILITIES 2,664,848 1,392,964
Redeemable convertible preferred stock - Series A; $0.0001 par value, 1,500 designated Series A, and 480 shares issued and outstanding (liquidation preference of $714,000 and $693,580) as of September 30, 2022 and December 31, 2021 714,000 693,580
STOCKHOLDERS’ DEFICIT    
Common stock, $0.0001 par value, 300,000,000 shares authorized, 1,922,142 and 1,652,102 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively 193 165
Unearned deferred compensation (348,548) (900,742)
Additional paid-in capital 31,563,286 29,765,585
Accumulated deficit (33,628,332) (29,281,674)
TOTAL STOCKHOLDERS’ DEFICIT (2,413,399) (416,664)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT 965,449 1,669,880
Series B Preferred Stock [Member]    
STOCKHOLDERS’ DEFICIT    
Preferred stock, value 2 2
Series E-1 Preferred Stock [Member]    
STOCKHOLDERS’ DEFICIT    
Preferred stock, value